Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Neoplasm Metastasis × palbociclib × Clear all

Phase

Status

Sponsor Class

INDUSTRY 10 OTHER 8 OTHER_GOV 2 NIH 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 1 Recurrent Squamous Cell Lung Carcinoma 1 Prostatic Neoplasms 1 Oligodendroglioma 1 Neoplasms, Neuroepithelial 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Medulloblastoma 1 Lymphoma, Non-Hodgkin 1 Glioblastoma 1 Choroid Plexus Neoplasms 1 Astrocytoma 1

Interventions

Radiotherapy 9 Radiosurgery 6 Oxaliplatin 5 Cisplatin 5 Paclitaxel 4 Capecitabine 4 Leucovorin 3 Fluorouracil 3 Doxorubicin 3 Docetaxel 3 regorafenib 2 pembrolizumab 2 enzalutamide 2 Temozolomide 2 Radiofrequency Ablation 2 Mitomycin 2 Irinotecan 2 Ifosfamide 2 Gemcitabine 2 Filgrastim 2 Bleomycin 2 Bevacizumab 2 Analgesia 2 Albumin-Bound Paclitaxel 2 trifluridine tipiracil drug combination 1 spartalizumab 1 sargramostim 1 plozalizumab 1 palbociclib 1 orteronel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02536742 2024-02-26

PYTHIA

ETOP IBCSG Partners Foundation

Phase 2 Completed

124 enrolled 10 charts

Breast Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡